ANAB Overview
Upcoming Projects (ANAB)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ANAB)
-
A second look: Discussing the potential of Lilly's Peresolimab in treating Rheumatoid Arthritis with a focus on the Phase 2 trial data
Tickers: LLY, ANAB
Executed On: Sep 26, 2023 at 02:00 PM EDT -
Discussing the potential of Lilly's Peresolimab in treating Rheumatoid Arthritis with a focus on the Phase 2 trial data
Tickers: LLY, ANAB
Executed On: Sep 18, 2023 at 04:00 PM EDT
Expired Projects (ANAB)
-
A Look at Novartis' Cosentyx in treating Hidradenitis Suppurativa and how it can compete with Humira
Tickers: NVS, ABBV, ANAB
Execute By: Aug 08, 2022 -
Anaptys Bio's(ANAB) ANB019 (imsidolimab) in Acne Vulgaris -ACORN Phase 2 data due 1H 2022
Ticker: ANAB
Execute By: Mar 31, 2022
Upcoming & Overdue Catalysts (ANAB)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ANAB)
-
Anaptys Bio's(ANAB) ANB019 in Palmo-plantar pustular psoriasis - POPLAR Phase 2 data due 1Q 2021
Ticker: ANAB
Occurred on: Mar 08, 2021 -
AnaptysBio's (ANAB) Etokimab ATLAS Phase 2b Clinical Trial in Moderate-to-Severe Atopic Dermatitis Data Released
Tickers: ANAB, DERM
Occurred on: Nov 08, 2019 -
AnaptysBio's ANB020 in Severe adult peanut allergy Phase 2a data due 1Q 2018
Ticker: ANAB
Occurred on: Feb 17, 2018
Strategic Initiatives (ANAB)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
